Peripheral Vascular Stents Market by Product and End User - Global Industry Analysis and Forecast to 2025

Published On : September 2017 Pages : 100 Category: Medical Devices Report Code : HC06147

Industry Trend Analysis

Peripheral Vascular Stents Market is expected to experience a moderate growth in coming years between 2014 and 2022. The market is expected to reach $9.38 billion by 2022 at a moderately growing CAGR of 5.88%. Peripheral vascular stents devices are used to diagnose peripheral artery disease (PAD). The PAD is characterized by building plaque in the arteries which in turn blocks the arteries and restricts the blood flow to the organs. When this condition is left untreated, it can lead to gangrene and in turn it may end up to amputation of limbs. Sometimes, it may also result into blockage of artery which can even lead to stroke. The increasing incidence of PAD across the globe, rising geriatric population and technological innovation related to peripheral vascular stents, will be the major drivers of the peripheral vascular stents market over the forecast period. Peripheral artery disease (PAD) is a common phenomenon among the geriatric population. For instance, as per CDC, in US, more than 8.3 million people suffered from PAD in 2016. This indicates increase in demand of peripheral vascular stents devices in the upcoming years. In addition, development of new imaging techniques is expected to improvise the vascular surgeries involving placement of peripheral vascular stents which in turn will increase the demand of stenting procedures. However, high price of peripheral stents and lack of awareness among general population about PAD, will restrain the growth of the peripheral vascular stents market in the future years. Thus, considering the drivers and challenges, peripheral vascular stents market is expected to have a moderate growth over the forecast period.

Product Outlook and Trend Analysis

Innovation is set to derive the demand for peripheral vascular stents globally. Therefore, key players are highly focused on developing innovative peripheral vascular stents to meet the unmet medical needs. For instance, in February 2016, Boston Scientific obtained CE Mark for its Eluvia Drug-Eluting Vascular Stent System, which can restore blood flow in the peripheral arteries. This system provides a unique drug-polymer combination to provide continued release of the drug for preventing narrowing of the vessel. Likewise, in June 2015, Terumo Interventional Systems launched its MISAGO RX Self-expanding Peripheral Stent to treat patients with peripheral artery disease in the proximal popliteal and superficial femoral artery. Such product developments helped these companies to strengthen their product portfolio to sustain their position in the market.

Regional Outlook and Trend Analysis

North America held a significant share of the peripheral vascular stents market in 2016 due to the increase in geriatric population and occurrence of PAD in various states. In addition, technological innovation of the devices by the key players of the market will also enhance the market growth in this region. The Asia-Pacific market has not experienced any substantial growth due to lack of large scale adoption of peripheral vascular stents but can experience favorable growth in coming years owing to changing lifestyles related to peripheral vascular stents  and increasing geriatric population  in the region.

Competitive Outlook and Trend Analysis

The key players operating in the peripheral vascular stents market emphasizes on product development in order to introduce improve peripheral vascular stents devices and capture a larger share of the market.  Some of the major players in this market are Boston Scientific, Terumo Medical Corporation, Abbott Laboratories, Braun Melsungen, Biotronik,, Cook Medical, C.R. Bard, Intact Vascular, W.L. Gore & Associates, Medtronic, Edward Lifesciences Corporation, and AngioScore.

Market Opportunities

The key opportunity for the players operating in peripheral vascular stents market lies in the development of various types of cost effective peripheral stents for better assistance of the patients. Apart from that, innovative marketing strategies will further broaden the opportunities of the key players to grow significantly over the forecast period. In addition, changing lifestyles for peripheral vascular stents, will further increase demand of this market, creating a lucrative opportunities for growth, for the key players of this market.

Peripheral Vascular Stents Market Segmentation

By Product

  • Balloon Expanding Stent
  • Self-expanding Stent
  • Drug Eluting Stent
  • Bare Metal Stent

By End User

  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Hospitals

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2016 and forecast from 2017 to 2025?
  • What will be the industry market growth from 2017 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

 

Market Classification

  • Peripheral Vascular Stents  Market, By Product, Estimates and Forecast, 2014-2022 ($Billion)
    • Balloon Expanding Stent
    • Self-Expanding Stent
    • Drug Eluting Sent
    • Bare Metal Stent
  • Peripheral Vascular Stents Market, By End User, Estimates and Forecast, 2014-2022 ($Billion)
    • Ambulatory Surgical Centers
    • Specialty Clinics
    • Hospitals
  • Peripheral Vascular Stents Market, By Region, Estimates and Forecast, 2014-2022 ($Billion)
    • North America
      • North America  Peripheral Vascular Stents Market, By Country
      • North America  Peripheral Vascular Stents Market, By Product
      • North America  Peripheral Vascular Stents Market, By End User
        • U.S.  Peripheral Vascular Stents Market, By Product
        • U.S. Peripheral Vascular Stents Market, By End User
        • Canada  Peripheral Vascular Stents Market, By Product
        • Canada  Peripheral Vascular Stents Market, By End User
        • Mexico  Peripheral Vascular Stents Market, By Product
        • Mexico  Peripheral Vascular Stents Market, By End User
    • Europe
  • Europe Peripheral Vascular Stents Market, By Country
  • Europe Peripheral Vascular Stents Market, By Product
  • Europe Peripheral Vascular Stents Market, By End User
    • Germany  Peripheral Vascular Stents Market, By Product
    • Germany  Peripheral Vascular Stents Market, By End User
    • France Peripheral Vascular Stents Market, By Product
    • France Peripheral Vascular Stents Market, By End User
    • UK   Peripheral Vascular Stents Market, By Product
    • UK   Peripheral Vascular Stents Market, By End User
    • Italy   Peripheral Vascular Stents Market, By Product
    • Italy   Peripheral Vascular Stents Market, By End User
    • Spain   Peripheral Vascular Stents Market, By Product
    • Spain   Peripheral Vascular Stents Market, By End User
    • Rest of Europe   Peripheral Vascular Stents Market, By Product
    • Rest of Europe   Peripheral Vascular Stents Market, By End User
    • Asia-Pacific
      • Asia-Pacific   Peripheral Vascular Stents Market, By Country
      • Asia-Pacific   Peripheral Vascular Stents Market, By Product
      • Asia-Pacific   Peripheral Vascular Stents Market, By End User
        • Japan   Peripheral Vascular Stents Market, By Product
        • Japan   Peripheral Vascular Stents Market, By End User
        • Australia   Peripheral Vascular Stents Market, By Product
        • Australia   Peripheral Vascular Stents Market, By End User
        • India   Peripheral Vascular Stents Market, By Product
        • India   Peripheral Vascular Stents Market, By End User
        • South Korea   Peripheral Vascular Stents Market, By Product
        • South Korea   Peripheral Vascular Stents Market, By End User
        • Rest of Asia-Pacific   Peripheral Vascular Stents Market, By Product
        • Rest of Asia-Pacific   Peripheral Vascular Stents Market, By End User
    • Rest of the World
      • Rest of the World   Peripheral Vascular Stents Market, By Country
      • Rest of the World   Peripheral Vascular Stents Market, By Product
      • Rest of the World   Peripheral Vascular Stents Market, By End User
        • Brazil   Peripheral Vascular Stents Market, By Product
        • Brazil   Peripheral Vascular Stents Market, By End User
        • South Africa   Peripheral Vascular Stents Market, By Product
        • South Africa   Peripheral Vascular Stents Market, By End User
        • Saudi Arabia   Peripheral Vascular Stents Market, By Product
        • Saudi Arabia   Peripheral Vascular Stents Market, By End User
        • Turkey   Peripheral Vascular Stents Market, By Product
        • Turkey   Peripheral Vascular Stents Market, By End User
        • United Arab Emirates   Peripheral Vascular Stents Market, By Product
        • United Arab Emirates   Peripheral Vascular Stents Market, By End User
        • Others   Peripheral Vascular Stents Market, By Product
        • Others   Peripheral Vascular Stents Market, By End User

Table of Contents

1.Introduction

1.1.Report Description

1.2.Research Methodology

2.Executive Summary

2.1.Key Highlights

3.Market Overview

3.1.Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.Market Share Analysis

3.3.Market Dynamics

3.3.1. Drivers

3.3.1.1.Increasing Geriatric Population andincidence of PAD

3.3.1.2.Technological Innovation and Increasing Promotional Activities

3.3.1.3.Changing Lifestyles and Increasing Adoption

3.3.2. Restraints

3.3.2.1.High Pricing of the Product

3.3.2.2.Low Awareness among General Population

3.3.3. Opportunities

3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities

3.4.Industry Trends

4.Peripheral Vascular Stents Market, By Product

4.1.Introduction

4.2.Peripheral Vascular Stents Market Assessment and Forecast, By Product, 2014-2022

4.3.Balloon Expanding Stent

4.3.1. Market Assessment and Forecast, By Region, 2014-2022 ($Billion)

4.4.Self-Expanding Stent

4.4.1. Market Assessment and Forecast, By Region, 2014-2022 ($Billion)

4.5.Drug Eluting Stent

4.5.1. Market Assessment and Forecast, By Region, 2014-2022 ($Billion)

4.6.Bare Metal Stent

4.6.1. Market Assessment and Forecast, By Region, 2014-2022 ($Billion)

5.Peripheral Vascular Stents Market, By End Users

5.1.Introduction

5.2.The Peripheral Vascular Stents Market Assessment and Forecast, By End Users, 2014-2022

5.3.Ambulatory Surgical Centers

5.3.1. Market Assessment and Forecast, By Region, 2014-2022 ($Billion)

5.4.Specialty Clinics

5.4.1. Market Assessment and Forecast, By Region, 2014-2022 ($Billion)

5.5.Hospitals

5.5.1. Market Assessment and Forecast, By Region, 2014-2022 ($Billion)

6.Peripheral Vascular Stents Market, By Region

6.1.Introduction

6.2.Peripheral Vascular Stents Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.3.Peripheral Vascular Stents Market Assessment and Forecast, By End Users , 2014-2022 ($Billion)

6.4.North America

6.4.1. Market Assessment and Forecast, By Country, 2014-2022 ($Billion)

6.4.2. Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.4.3. Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.4.4. U.S.

6.4.4.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.4.4.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.4.5. Canada

6.4.5.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.4.5.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.4.6. Mexico

6.4.6.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.4.6.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.Europe

6.5.1. Market Assessment and Forecast, By Country, 2014-2022 ($Billion)

6.5.2. Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.3. Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.4. Germany

6.5.4.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.4.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.5. France

6.5.5.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.5.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.6. UK

6.5.6.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.6.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.7. Italy

6.5.7.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.7.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.8. Spain

6.5.8.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.8.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.9. Russia

6.5.9.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.9.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.5.10.Rest of Europe

6.5.10.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.5.10.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.Asia-Pacific

6.6.1. Market Assessment and Forecast, By Country, 2014-2022 ($Billion)

6.6.2. Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.3. Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.4. Japan

6.6.4.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.4.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.5. China

6.6.5.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.5.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.6. Australia

6.6.6.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.6.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.7. India

6.6.7.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.7.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.8. South Korea

6.6.8.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.8.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.9. Taiwan

6.6.9.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.9.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.6.10.Rest of Asia-Pacific

6.6.10.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.6.10.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.7.Rest of the World

6.7.1. Market Assessment and Forecast, By Country, 2014-2022 ($Billion)

6.7.2. Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.7.3. Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.7.4. Brazil

6.7.4.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.7.4.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.7.5. Turkey

6.7.5.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.7.5.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.7.6. Saudi Arabia

6.7.6.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.7.6.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.7.7. South Africa

6.7.7.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.7.7.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.7.8. United Arab Emirates

6.7.8.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.7.8.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

6.7.9. Others

6.7.9.1.Market Assessment and Forecast, By Product, 2014-2022 ($Billion)

6.7.9.2.Market Assessment and Forecast, By End Users, 2014-2022 ($Billion)

7.Company Profiles

7.1.Boston Scientific

7.1.1. Business Overview

7.1.2. Product Portfolio

7.1.3. Key Financials

7.1.4. Strategic Developments

7.2.Terumo Medical Corporation

7.2.1. Business Overview

7.2.2. Product Portfolio

7.2.3. Strategic Developments

7.3.Abbott Laboratories

7.3.1. Business Overview

7.3.2. Product Portfolio

7.3.3. Strategic Developments

7.4.Braun Melsungen

7.4.1. Business Overview

7.4.2. Product Portfolio

7.4.3. Strategic Developments

7.5.Biotronik

7.5.1. Business Overview

7.5.2. Product Portfolio

7.5.3. Strategic Developments

7.6.Cook Medical

7.6.1. Business Overview

7.6.2. Product Portfolio

7.6.3. Strategic Developments

7.7.C.R. Bard

7.7.1. Business Overview

7.7.2. Product Portfolio

7.7.3. Key Financials

7.7.4. Strategic Developments

7.8.Intact Vascular

7.8.1. Business Overview

7.8.2. Product Portfolio

7.8.3. Strategic Developments

7.9.W.L. Gore & Associates

7.9.1. Business Overview

7.9.2. Product Portfolio

7.9.3. Strategic Developments

7.10.Medtronic

7.10.1.Business Overview

7.10.2.Product Portfolio

7.10.3.Strategic Developments

7.11.Edward Life sciences Corporation

7.11.1.Business Overview

7.11.2.Product  Portfolio

7.11.3.Key Financials

7.11.4.Strategic Developments

7.12.AngioScore

7.12.1.Business Overview

7.12.2.Product Portfolio

7.12.3.Strategic Developments

 


List of Tables

Table 1.Global Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 2.Balloon Expanding Stents Market, By Region, 2014-2022 ($Billion)
Table 3.Self- Expanding Stents Market, By Region, 2014-2022 ($Billion)
Table 4.Drug Eluting Stents Market, By Region, 2014-2022 ($Billion)
Table 5.Bare Metal Stents Market, By Region, 2014-2022 ($Billion)
Table 6.Peripheral Vascular Stents Market, By End User, 2014-2022 ($Billion)
Table 7.Ambulatory Surgical Centers Market, By Region, 2014-2022 ($Billion)
Table 8.Specialty Clinics Market, By Region, 2014-2022 ($Billion)
Table 9.Hospitals Market, By Region, 2014-2022 ($Billion)
Table 10.North America Peripheral Vascular Stents Market, By Country, 2014-2022 ($Billion)
Table 11.North America Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 12.North America Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 13.U.S. Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 14.U.S. Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 15.Canada Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 16.Canada Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 17.Mexico Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 18.Mexico Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 20.Europe Peripheral Vascular Stents Market, By Country, 2014-2022 ($Billion)
Table 21.Europe Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 22.Europe Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 23.Germany Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 24.Germany Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 25.France Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 26.France Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 27.UK Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 28.UK Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 29.Italy Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 30.Italy Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 31.Spain Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 32.Spain Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 33.Russia Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 34.Russia Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 35.Rest of Europe Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 36.Rest of Europe Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 37.Asia-Pacific Peripheral Vascular Stents Market, By Country, 2014-2022 ($Billion)
Table 38.Asia-Pacific Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 39.Asia-Pacific Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 40.Japan Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 41.Japan Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 42.China Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 43.China Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 44.Australia Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 45.Australia Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 46.India Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 47.India Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 48.South Korea Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 49.South Korea Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 50.Rest of Asia-Pacific Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 51.Rest of Asia-Pacific Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 52.Rest of the World Peripheral Vascular Stents Market, By Country, 2014-2022 ($Billion)
Table 53.Rest of the World Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 54.Rest of the World Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 55.Brazil Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 56.Brazil Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 57.Turkey Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 58.Turkey Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 59.Saudi Arabia Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 60.Saudi Arabia Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 61.South Africa Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 62.South Africa Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 63.United Arab Emirates Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 64.United Arab Emirates Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 65.Others Peripheral Vascular Stents Market, By Product, 2014-2022 ($Billion)
Table 66.Others Peripheral Vascular Stents Market, By End Users, 2014-2022 ($Billion)
Table 67.Boston Scientific: Key Strategic Developments, 2015-2017
Table 68.Terumo Medical Corporation: Key Strategic Developments, 2015-2017
Table 69.Abbott Laboratories: Key Strategic Developments, 2015-2017
Table 70.Braun Melsungen: Key Strategic Developments, 2015-2017
Table 71.Biotronik: Key Strategic Developments, 2015-2017
Table 72.Cook Medical: Key Strategic Developments, 2015-2017
Table 73.C.R. Bard: Key Strategic Developments, 2015-2017
Table 74.Intact Vascular: Key Strategic Developments, 2015-2017
Table 75.W.L. Gore & Associates: Key Strategic Developments, 2015-2017
Table 76.Medtronic: Key Strategic Developments, 2015-2017
Table 77.Edward Lifesciences Corporation: Key Strategic Developments, 2015-2017
Table 78.AngioScore: Key Strategic Developments, 2015-2017


List of Figures

Figure 1.Global Peripheral Vascular Stents Market Share, By Product, 2016 & 2025
Figure 2.Global Peripheral Vascular Stents Market, By End Users, 2016, ($Billion)
Figure 3.Global Peripheral Vascular Stents Market, By Region, 2016, ($Billion)
Figure 4.Boston Scientific: Net Revenues, 2014-2016 ($Billion)
Figure 5.Boston Scientific: Net Revenue Share, By Segment, 2016
Figure 6.Boston Scientific: Net Revenue Share, By Geography, 2016
Figure 7.C.R. Bard: Net Revenues, 2014-2016 ($Billion)
Figure 8.C.R. Bard: Net Revenue Share, By Segment, 2016
Figure 9.C.R. Bard: Net Revenue Share, By Geography, 2016
Figure 10.Edward Life sciences Corporation: Net Revenues, 2014-2016 ($Billion)
Figure 11.Edward Life sciences Corporation: Net Revenue Share, By Segment, 2016
Figure 12.Edward Life sciences Corporation: Net Revenue Share, By Geography, 2016

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Licesnces Type

For Any Assistance

*
*
*